This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shultz, T. R.
Right arrow Articles by White, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shultz, T. R.
Right arrow Articles by White, P. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 2001, p. 734-738, Vol. 45, No. 3
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.3.734-738.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Correlation of In Vitro Susceptibilities to Newer Quinolones of Naturally Occurring Quinolone-Resistant Neisseria gonorrhoeae Strains with Changes in GyrA and ParC

Tiffany R. Shultz,* John W. Tapsall, and Peter A. White

Department of Microbiology, The Prince of Wales Hospital, Randwick, Sydney, New South Wales, Australia 2031

Received 25 August 2000/Returned for modification 26 September 2000/Accepted 19 November 2000

The in vitro activities of ciprofloxacin, trovafloxacin, moxifloxacin, and grepafloxacin against 174 strains of Neisseria gonorrhoeae isolated in Sydney, Australia, were determined. The strains included 84 quinolone-less-sensitive and -resistant N. gonorrhoeae (QRNG) strains for which ciprofloxacin MICs were in the range of 0.12 to 16 µg/ml. The QRNG included strains isolated from patients whose infections were acquired in a number of countries, mostly in Southeast Asia. The gyrA and parC quinolone resistance-determining regions (QRDR) of 18 selected QRNG strains were sequenced, and the amino acid mutations observed were related to the MICs obtained. The activities of moxifloxacin and grepafloxacin against QRNG were comparable to that of ciprofloxacin. Trovafloxacin was more active than the other quinolones against some but not all of the QRNG strains. Increments in ciprofloxacin resistance occurred in a step-wise manner with point mutations initiated in gyrA resulting in amino acid alterations Ser91-to-Phe, Ser91-to-Tyr, Asp95-to-Gly, and Asp95-to-Asn. Single gyrA changes correlated with ciprofloxacin MICs in the range 0.12 to 1 µg/ml. The Ser91 changes in GyrA were associated with higher MICs and further QRDR changes. QRNG strains for which ciprofloxacin MICs were greater than 1 µg/ml had both gyrA and parC QRDR point mutations. ParC alterations were seen in these isolates only in the presence of GyrA changes and comprised amino acid changes Asp86-to-Asn, Ser87-to-Asn, Ser87-to-Arg, Ser88-to-Pro, Glu91-to-Lys, and Glu91-to-Gln. QRNG strains for which MICs were in the higher ranges had double GyrA mutations, but again only with accompanying ParC alterations. Not only did the nature and combination of GyrA and ParC changes influence the incremental increases in ciprofloxacin MICs, but they seemingly also altered the differential activity of trovafloxacin. Our findings suggest that the newer quinolones of the type examined are unlikely to be useful replacements for ciprofloxacin in the treatment of gonorrhea, particularly where ciprofloxacin MICs are high or where resistance is widespread.

* Corresponding author. Mailing address: Department of Microbiology, The Prince of Wales Hospital, High Street, Randwick, NSW 2031, Australia. Phone: 61 2 9382 9084. Fax: 61 2 9398 4275. E-mail: shultztr{at}sesahs.nsw.gov.au.

Antimicrobial Agents and Chemotherapy, March 2001, p. 734-738, Vol. 45, No. 3
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.3.734-738.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Allen, G. P., Hankins, C. D. (2009). Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae. J Antimicrob Chemother 64: 359-363 [Abstract] [Full Text]  
  • Vernel-Pauillac, F., Hogan, T. R., Tapsall, J. W., Goarant, C. (2009). Quinolone Resistance in Neisseria gonorrhoeae: Rapid Genotyping of Quinolone Resistance-Determining Regions in gyrA and parC Genes by Melting Curve Analysis Predicts Susceptibility. Antimicrob. Agents Chemother. 53: 1264-1267 [Abstract] [Full Text]  
  • Wang, B., Xu, J.-s., Wang, C.-x., Mi, Z.-h., Pu, Y.-p., Hui, M., Ling, T. K. W., Chan, C.-Y. (2006). Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Jiangsu Province, China, with a focus on fluoroquinolone resistance.. J Med Microbiol 55: 1251-1255 [Abstract] [Full Text]  
  • Sierra, J. M., Martinez-Martinez, L., Vazquez, F., Giralt, E., Vila, J. (2005). Relationship between Mutations in the gyrA Gene and Quinolone Resistance in Clinical Isolates of Corynebacterium striatum and Corynebacterium amycolatum. Antimicrob. Agents Chemother. 49: 1714-1719 [Abstract] [Full Text]  
  • Shultz, T. R., White, P. A., Tapsall, J. W. (2005). In Vitro Assessment of the Further Potential for Development of Fluoroquinolone Resistance in Neisseria meningitidis. Antimicrob. Agents Chemother. 49: 1753-1760 [Abstract] [Full Text]  
  • Zhou, W., Du, W., Cao, H., Zhao, J., Yang, S., Li, W., Shen, Y., Zhang, S., Du, W., Zhang, X. (2004). Detection of gyrA and parC Mutations Associated with Ciprofloxacin Resistance in Neisseria gonorrhoeae by Use of Oligonucleotide Biochip Technology. J. Clin. Microbiol. 42: 5819-5824 [Abstract] [Full Text]  
  • Yong, D., Kim, T. S., Choi, J. R., Yum, J. H., Lee, K., Chong, Y., Oh, H.-B., Shultz, T., Tapsall, J. W. (2004). Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonorrhoeae strains isolated in Korea and nearby countries. J Antimicrob Chemother 54: 451-455 [Abstract] [Full Text]  
  • Vereshchagin, V. A., Ilina, E. N., Malakhova, M. V., Zubkov, M. M., Sidorenko, S. V., Kubanova, A. A., Govorun, V. M. (2004). Fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Russia: molecular mechanisms implicated. J Antimicrob Chemother 53: 653-656 [Abstract] [Full Text]  
  • Kam, K. M., Kam, S. S. Y., Cheung, D. T. L., Tung, V. W. N., Au, W. F., Cheung, M. M. (2003). Molecular Characterization of Quinolone-Resistant Neisseria gonorrhoeae in Hong Kong. Antimicrob. Agents Chemother. 47: 436-439 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»